Literature DB >> 23210322

Bloodstream infections in immunocompromised hosts.

Raluca Papagheorghe1.   

Abstract

Immunocompromised hosts are at high risk for bloodstream infections (BSIs); the outcome is unpredictable (even with adequate therapy), frequently severe (mortality 27%). A 26 months survey in a haematology/oncology hospital was set-up; it comprised 158 patients and detected 171 positive blood cultures. The origin of the infections was primitive in 27.22% and secondary in 72.78% of the cases; the most frequent cause was the presence of a vascular catheter (23.41%). The second most important cause were the respiratory infections (19.62%), followed by the urinary tract infections (UTIs) (11.39%). Gram negative bacilli represented 59.4%, the enterobacteriaceae were predominant (35.59%), followed by Pseudomonas aeruginosa (10.73%) and species like Serratia marcescens and Acinetobacter baumannii. Although isolated at low level, they worry by an increasing frequency. Among Gram positive cocci (43.51%) coagulase negative staphylococci (CoNS) were the most frequent (25.42%), followed by Staphylococcus aureus (18.08%); Enterococcus faecalis (5.65%) was isolated from polymicrobial (associated) infections. The strains of E. coli, K. pneumoniae and P. aeruginosa were constantly susceptible to carbapenems, demonstrating otherwise various susceptibility patterns, generally elevated to the antibiotics we tested. The production of extended spectrum betalactamase (ESBL) was 22.58%. The methicillin resistance was 54.4% in S. aureus strains; the susceptibility was variable among 7 other antibiotics tested. One Staphylococcus strain had reduced susceptibility to vancomycin. A multidisciplinary survey is necessary for the control of the multidrug resistant organisms (MDRO).

Entities:  

Mesh:

Year:  2012        PMID: 23210322

Source DB:  PubMed          Journal:  Roum Arch Microbiol Immunol        ISSN: 1222-3891


  4 in total

1.  Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.

Authors:  Youn Jeong Kim; Yoon Hee Jun; Yang Ree Kim; Kang Gyun Park; Yeon Joon Park; Ji Young Kang; Sang Il Kim
Journal:  BMC Infect Dis       Date:  2014-03-24       Impact factor: 3.090

Review 2.  The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes.

Authors:  Yuta Okkotsu; Alexander S Little; Michael J Schurr
Journal:  Front Cell Infect Microbiol       Date:  2014-06-20       Impact factor: 5.293

3.  Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies.

Authors:  Su Yu Tang; Shun Wen Zhang; Jiang Dong Wu; Fang Wu; Jie Zhang; Jiang Tao Dong; Peng Guo; Da Long Zhang; Jun Ting Yang; Wan Jiang Zhang
Journal:  Exp Ther Med       Date:  2018-01-09       Impact factor: 2.447

4.  Pseudomonas aeruginosa AlgR Phosphorylation Status Differentially Regulates Pyocyanin and Pyoverdine Production.

Authors:  Alexander S Little; Yuta Okkotsu; Alexandria A Reinhart; F Heath Damron; Mariette Barbier; Brandon Barrett; Amanda G Oglesby-Sherrouse; Joanna B Goldberg; William L Cody; Michael J Schurr; Michael L Vasil; Michael J Schurr
Journal:  mBio       Date:  2018-01-30       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.